Put Options

30 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$189.07 - $236.8 $75,628 - $94,720
-400 Reduced 0.25%
158,500 $30.7 Million
Q2 2024

Aug 13, 2024

SELL
$190.52 - $236.72 $2.65 Million - $3.29 Million
-13,900 Reduced 8.04%
158,900 $36.8 Million
Q1 2024

May 13, 2024

SELL
$212.02 - $267.71 $18.4 Million - $23.2 Million
-86,700 Reduced 33.41%
172,800 $37.3 Million
Q4 2023

Feb 09, 2024

SELL
$222.59 - $267.94 $1.42 Million - $1.71 Million
-6,400 Reduced 2.41%
259,500 $67.2 Million
Q3 2023

Nov 09, 2023

BUY
$253.3 - $285.89 $30.1 Million - $33.9 Million
118,700 Added 80.64%
265,900 $68.3 Million
Q2 2023

Aug 11, 2023

BUY
$275.25 - $318.06 $3.08 Million - $3.56 Million
11,200 Added 8.24%
147,200 $41.9 Million
Q1 2023

May 12, 2023

SELL
$256.56 - $292.34 $7.88 Million - $8.97 Million
-30,700 Reduced 18.42%
136,000 $37.8 Million
Q4 2022

Feb 08, 2023

BUY
$252.44 - $306.72 $3.56 Million - $4.32 Million
14,100 Added 9.24%
166,700 $46.2 Million
Q3 2022

Nov 10, 2022

BUY
$194.69 - $268.46 $3.41 Million - $4.7 Million
17,500 Added 12.95%
152,600 $40.7 Million
Q2 2022

Aug 10, 2022

BUY
$187.54 - $223.02 $3.3 Million - $3.93 Million
17,600 Added 14.98%
135,100 $27.6 Million
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $26.7 Million - $33.7 Million
-138,000 Reduced 54.01%
117,500 $24.7 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $2.92 Million - $3.75 Million
13,034 Added 5.38%
255,500 $61.3 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $7.61 Million - $9.93 Million
-26,900 Reduced 9.99%
242,466 $68.6 Million
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $13.2 Million - $21.2 Million
51,000 Added 23.36%
269,366 $93.3 Million
Q1 2021

May 12, 2021

BUY
$242.95 - $284.63 $8.84 Million - $10.4 Million
36,366 Added 19.98%
218,366 $61.1 Million
Q4 2020

Feb 11, 2021

BUY
$236.26 - $355.63 $6.31 Million - $9.5 Million
26,700 Added 17.19%
182,000 $44.6 Million
Q3 2020

Nov 12, 2020

SELL
$264.77 - $305.71 $18.5 Million - $21.4 Million
-70,000 Reduced 31.07%
155,300 $44.1 Million
Q2 2020

Jul 31, 2020

BUY
$258.66 - $342.55 $517,320 - $685,100
2,000 Added 0.9%
225,300 $60.3 Million
Q1 2020

May 01, 2020

BUY
$268.85 - $341.04 $21.2 Million - $26.9 Million
78,900 Added 54.64%
223,300 $70.6 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $1.36 Million - $1.89 Million
-6,200 Reduced 4.12%
144,400 $42.8 Million
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $10.9 Million - $12.2 Million
50,000 Added 49.7%
150,600 $35.1 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $4.61 Million - $5.08 Million
-21,000 Reduced 17.27%
100,600 $23.5 Million
Q1 2019

May 14, 2019

BUY
$216.71 - $338.96 $16.7 Million - $26.1 Million
77,100 Added 173.26%
121,600 $28.7 Million
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $5.43 Million - $6.88 Million
19,500 Added 78.0%
44,500 $13.4 Million
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $2.58 Million - $3.07 Million
10,000 Added 66.67%
25,000 $7.26 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $1.3 Million - $1.84 Million
-5,000 Reduced 25.0%
15,000 $4.11 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $276,876 - $310,122
-900 Reduced 4.31%
20,000 $6.37 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $4.51 Million - $5.28 Million
16,030 Added 329.16%
20,900 $6.54 Million
Q2 2017

Aug 14, 2017

BUY
N/A
670 Added 15.95%
4,870 $1.32 Million
Q1 2017

Nov 14, 2017

BUY
N/A
4,200
4,200 $1.15 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.